Johnson & Johnson’s (J&J) MedTech arm displayed resilience in its second quarter, navigating inflationary headwinds while prioritizing innovation. The unit, a key driver for J&J,...
The integration of robotics is reshaping surgical procedures, promising enhanced precision, efficiency, and improved patient outcomes. Recent earnings reports from industry giants like Intuitive Surgical and Johnson &...
Johnson & Johnson (J&J) has emphasized the pivotal role of medical technology (MedTech) in advancing healthcare. During a Tuesday (April 16) call with analysts to discuss...
Six months after parting ways with its consumer health unit, Kenvue, Johnson & Johnson has reported total sales of $21.4 billion for the last quarter of...
Riding high, Johnson & Johnson reported pharmaceutical sales worth $13.89 billion on Tuesday (Oct 17), a year-over-year growth exceeding 5%. The pharmaceuticals driving its growth...
Despite beating second-quarter revenue and earnings expectations in its first quarterly report since spinning out from Johnson & Johnson two months ago, Kenvue’s shares declined...
Johnson & Johnson’s consumer healthcare spinoff has made the biggest U.S. initial public offering (IPO) since 2021. Kenvue, which includes Band-Aid and several other well-known...
Johnson & Johnson is reportedly readying an investors roadshow to take its commercial healthcare unit public. According to a Sunday (April 23) Wall Street Journal...
As Johnson & Johnson readies for the separation of its consumer health division later this year into the consumer-focused company called Kenvue, the healthcare giant’s...